A detailed history of Sage Mountain Advisors LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Sage Mountain Advisors LLC holds 5,089 shares of GILD stock, worth $451,699. This represents 0.04% of its overall portfolio holdings.

Number of Shares
5,089
Previous 3,894 30.69%
Holding current value
$451,699
Previous $267,000 59.55%
% of portfolio
0.04%
Previous 0.02%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$66.59 - $83.99 $79,575 - $100,368
1,195 Added 30.69%
5,089 $426,000
Q2 2024

Jul 31, 2024

BUY
$63.15 - $72.88 $32,838 - $37,897
520 Added 15.41%
3,894 $267,000
Q1 2024

Apr 23, 2024

SELL
$71.58 - $87.29 $24,551 - $29,940
-343 Reduced 9.23%
3,374 $247,000
Q4 2023

Feb 01, 2024

BUY
$73.27 - $83.09 $25,278 - $28,666
345 Added 10.23%
3,717 $301,000
Q3 2023

Oct 25, 2023

BUY
$73.94 - $80.67 $3,475 - $3,791
47 Added 1.41%
3,372 $252,000
Q2 2023

Jul 24, 2023

BUY
$76.01 - $86.7 $6,080 - $6,936
80 Added 2.47%
3,325 $256,000
Q1 2023

Apr 25, 2023

BUY
$77.31 - $88.08 $250,870 - $285,819
3,245 New
3,245 $269,000
Q1 2022

May 10, 2022

SELL
$57.92 - $72.58 $293,191 - $367,399
-5,062 Closed
0 $0
Q4 2021

Feb 02, 2022

BUY
$64.88 - $73.64 $23,551 - $26,731
363 Added 7.73%
5,062 $368,000
Q3 2021

Nov 01, 2021

SELL
$67.69 - $73.03 $2,098 - $2,263
-31 Reduced 0.66%
4,699 $328,000
Q2 2021

Jul 22, 2021

BUY
$63.47 - $69.35 $300,213 - $328,025
4,730 New
4,730 $326,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $111B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Sage Mountain Advisors LLC Portfolio

Follow Sage Mountain Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sage Mountain Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sage Mountain Advisors LLC with notifications on news.